Clinical Trial Update: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [Phase 3]

View source ↗

Summary

Phase 3 ALLHAT trial update reporting completed results evaluating antihypertensive therapies (chlorthalidone, lisinopril, amlodipine, and doxazosin) for preven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Heart Failure
• Hyperlipidemia
• Hypertension
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Amlodipine (amlodipine)
• Chlorthalidone (chlorthalidone)
• Doxazosin (doxazosin)
• Lisinopril (Lisinopril)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED